Skip to main content
Premium Trial:

Request an Annual Quote

Genset Orders Molecular Dynamics DNA System


SUNNYVALE, Calif.--Molecular Dynamics announced that the French genomics company Genset placed a multiunit order for MegaBACE 1000 DNA sequencing systems. The systems will significantly expand Genset's sequencing capacity, claimed Molecular Dynamics.

The sequencer technology, developed jointly with Amersham Pharmacia Biotech, utilizes 96 capillary columns, operating in parallel, to separate, detect, and analyze fluorescently labeled DNA fragments. Molecular Dynamics said sequence read lengths typically exceed 500 base pairs per sample. The system automates gel matrix replacement, sample injection, DNA separation, and data analysis for significant productivity gains over traditional slab gel systems, the company claimed.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.